SCHEMBL10702749

SCHEMBL10702749

CN1CCc2cc(Sc3ccccc3)ccc2C(OC(=O)/C=C/C(=O)OC2CN(C)CCc3cc(Sc4ccccc4)ccc32)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD1 P21728 10/20 0.41
▸ DRD2 P14416 5/20 0.41
▸ DRD5 P21918 4/20 0.41
▸ HSD17B10 Q99714 4/20 0.39
▸ THPO P40225 2/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ HIF1A Q16665 1/20 0.39
▸ MTOR P42345 1/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ MAPT P10636 1/20 0.38
▸ BLM P54132 1/20 0.38
▸ PMP22 Q01453 1/20 0.38
▸ CYP2D6 P10635 4/20 0.38
▸ CYP3A4 P08684 2/20 0.38
▸ CYP1A2 P05177 3/20 0.36
▸ TSHR P16473 3/20 0.36
▸ NFKB1 P19838 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ ADCY2 Q08462 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10700513 0.84 CYP3A4 (0.47) DRD1DRD2DRD5SMN1; SMN2KDM4E
SCHEMBL11169289 0.75 CYP3A4 (0.38) DRD1DRD5SMN1; SMN2KDM4EMAPT
Fumaric Acid SCHEMBL10702753 0.74 SMN1; SMN2 (0.51) DRD1DRD2DRD5MAPK1SMN1; SMN2
Fumaric Acid SCHEMBL10702746 0.74 SMN1; SMN2 (0.51) DRD1DRD2DRD5MAPK1SMN1; SMN2
SCHEMBL11169440 0.74 KDM4E (0.32) DRD1DRD2DRD5SMN1; SMN2KDM4E
SCHEMBL10701951 0.70 DRD1 (0.49) DRD1DRD2DRD5SMN1; SMN2
SCHEMBL5462704 0.66 ESR1 (0.47) DRD1DRD2DRD5KDM4ESIGMAR1
SCHEMBL10110765 0.64 KDM4C (0.49) ALOX15
SCHEMBL7616589 0.63 DRD1 (0.68) DRD1DRD2DRD5HSD17B10THPO
SCHEMBL11566588 0.63 DRD1 (0.68) DRD1DRD2DRD5HSD17B10THPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0285287-A2 3-Benzazepine compounds for use in treating gastrointestinal motility disorders SMITHKLINE BEECHAM CORPORATION (US) 1988-10-05 — — EP disclosed
Send feedback